ClinicalTrials.Veeva

Menu

Stimulating the Social Brain

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Healthy Adults

Treatments

Device: sham tDCS
Device: active anodal tDCS

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study investigates whether the way in which individuals process social stimuli can be altered, and specifically, whether feelings of paranoia and suspiciousness can be reduced by stimulating the brain's regulatory regions via transcranial Direct Current Stimulation (tDCS).

Full description

Although paranoid ideation is typically associated with severe mental illnesses such as schizophrenia or bipolar disorder, 10-15% of individuals in the general population report experiencing paranoid thoughts on a regular basis. These individuals who are high in sub-clinical paranoia can show impaired work and social functioning as compared to individuals low in sub-clinical paranoia. The wide spread prevalence and negative functional impact of heightened paranoia reinforces the need to develop interventions that may help to reduce problematic patterns of paranoid thinking in both healthy individuals and those with mental illness.

Transcranial Direct Current Stimulation (tDCS) is a form of noninvasive neurostimulation which has been proposed as a therapeutic procedure in numerous psychiatric conditions. TDCS therefore may be a promising therapeutic technique for reducing symptoms of psychosis, and specifically paranoia. This study will compare experiences of paranoid ideation in individuals who are high in sub-clinical paranoia across two conditions: active anodal tDCS and sham tDCS.

Enrollment

40 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • between the ages of 18 ad 35
  • previous classification as being high in sub-clinical paranoia

Exclusion criteria

  • diagnosis of mental illness
  • use of psychotropic medication
  • Presence or history of medical, cardiac, or neurological disorders that may affect brain function (e.g., cardiac disease, endocrine disorders, renal disease, pulmonary disease, history of seizures or head trauma with unconsciousness for a period of 15 minutes or greater or CNS tumors)
  • Presence of sensory limitation including visual (e.g., blindness, glaucoma, vision uncorrectable to 20/40) or hearing (e.g. hearing loss) impairments that interfere with assessment
  • Not proficient in English
  • Contraindications for tDCS (e.g., pregnancy or implanted devices such as pace maker)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

40 participants in 2 patient groups

Active anodal tDCS, Then Sham tDCS
Experimental group
Description:
Active anodal tDCS followed by behavioral testing; one week later, sham tDCS followed by behavioral testing
Treatment:
Device: active anodal tDCS
Device: sham tDCS
Sham tDCS, then Active anodal tDCS
Sham Comparator group
Description:
Sham tDCS followed by behavioral testing; one week later, active anodal tDCS followed by behavioral testing.
Treatment:
Device: active anodal tDCS
Device: sham tDCS

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems